Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Product/R&D News
5/15/2025
Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...
5/14/2025
Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...
5/14/2025
CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
5/14/2025
RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
5/14/2025
Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
5/14/2025
BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...
5/14/2025
NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
5/12/2025
CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...
5/12/2025
CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...
5/12/2025
AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...
5/12/2025
Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
5/7/2025
Roche's Columvi Wins Expanded Approval in China for 2L+ DLBCL
5/7/2025
Everest Medicines Announces NMPA Full Approval of NEFECON
5/7/2025
Early Clinical Data from China Show Promise for In Vivo CAR-T Therapie...
5/6/2025
Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance
5/6/2025
China Approves Six Novel Drugs in April 2025, Marking Significant Adva...
5/6/2025
Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...
5/6/2025
CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...
4/29/2025
53 Original Research Drugs Approved in China in Early 2025
4/29/2025
BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China
4/29/2025
Innovent Announces NMPA Approval of Limertinib
4/29/2025
Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...
4/29/2025
XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...
4/29/2025
CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...
4/29/2025
Innovent Initiates Global Phase 1 Trial for ADC IBI3020
4/29/2025
Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial
4/25/2025
China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...
4/25/2025
Akeso's Ivonescimab Gains Second Approval in China
4/25/2025
Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma
4/25/2025
NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...
Page:
3
/
14
Total number of articles:
409
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit